Literature DB >> 28661513

Mid-childhood outcomes after pre-viable preterm premature rupture of membranes.

M H Bentsen1,2, E Satrell2, H Reigstad1, S L Johnsen3, M Vollsæter1,2, O D Røksund1,4, G Greve2,5, A Berg1,2, T Markestad1,2, T Halvorsen1,2.   

Abstract

OBJECTIVES: Investigate cardiorespiratory outcomes in children surviving previable preterm premature rupture of membranes (PV-PPROM) before 22 weeks' gestational age (GA) with minimum 2 weeks latency. STUDY
DESIGN: Single institution, follow-up of retrospectively identified children who were born after PV-PPROM during 2000-2004, and individually matched preterm-born controls.
RESULTS: Eleven PV-PPROM and matched control children were included at mean age of 10.5 and 10.7 years. Rupture of membranes occurred at mean GA 182 and 276 weeks and birth at 283 and 286 weeks, respectively. Compared to controls, the PV-PPROM group had significantly poorer lung function, findings on echocardiography indicating mild pulmonary hypertension, and lower peak oxygen consumption. Chart reviews suggested more motor difficulties and a tendency towards more problems with learning and attention.
CONCLUSION: The findings highlight a preterm-born sub-group in need of targeted long-term monitoring and possibly interventions regarding future cardiorespiratory and neurodevelopmental function.

Entities:  

Mesh:

Year:  2017        PMID: 28661513     DOI: 10.1038/jp.2017.97

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  38 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

2.  Role of lung fluid volume in growth and maturation of the fetal sheep lung.

Authors:  A C Moessinger; R Harding; T M Adamson; M Singh; G T Kiu
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

3.  Neonatal and early childhood outcomes following early vs later preterm premature rupture of membranes.

Authors:  Tracy Ann Manuck; Michael Walter Varner
Journal:  Am J Obstet Gynecol       Date:  2014-05-22       Impact factor: 8.661

4.  Previable preterm rupture of membranes: gestational and neonatal outcomes.

Authors:  Marcela Furlan Margato; Guilherme Lopes Pinheiro Martins; Renato Passini Júnior; Marcelo Luís Nomura
Journal:  Arch Gynecol Obstet       Date:  2011-12-28       Impact factor: 2.344

5.  Lung function in white children aged 4 to 19 years: II--Single breath analysis and plethysmography.

Authors:  M Rosenthal; D Cramer; S H Bain; D Denison; A Bush; J O Warner
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

6.  Bruce treadmill test in children: normal values in a clinic population.

Authors:  G R Cumming; D Everatt; L Hastman
Journal:  Am J Cardiol       Date:  1978-01       Impact factor: 2.778

7.  Right ventricular function in infants, children and adolescents: reference values of the tricuspid annular plane systolic excursion (TAPSE) in 640 healthy patients and calculation of z score values.

Authors:  Martin Koestenberger; William Ravekes; Allen D Everett; Hans Peter Stueger; Bernd Heinzl; Andreas Gamillscheg; Gerhard Cvirn; Arnulf Boysen; Andrea Fandl; Bert Nagel
Journal:  J Am Soc Echocardiogr       Date:  2009-05-07       Impact factor: 5.251

8.  Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study.

Authors:  Michael D Pettersen; Wei Du; Mary Ellen Skeens; Richard A Humes
Journal:  J Am Soc Echocardiogr       Date:  2008-04-11       Impact factor: 5.251

9.  Normal standards for an incremental progressive cycle ergometer test.

Authors:  N L Jones; L Makrides; C Hitchcock; T Chypchar; N McCartney
Journal:  Am Rev Respir Dis       Date:  1985-05

10.  Tricuspid annular plane systolic excursion is reduced in infants with pulmonary hypertension.

Authors:  Dala Zakaria; Ritu Sachdeva; Jeffrey M Gossett; Xinyu Tang; Matthew J O'Connor
Journal:  Echocardiography       Date:  2014-10-07       Impact factor: 1.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.